Company / SG&A Expense
Xencor Inc SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$63.6M
FY2025
5-year range
$24.3M / $63.6M
FY2021-FY2025
Trend
+4.0%
vs FY2024
Sector context
#140 of 213
Health Care
What the data says
At $64M, Xencor Inc's sg&a expense ranks #74 of 213 in the Health Care sector. SG&A Expense has increased for 4 consecutive years, from $24M in FY2021 to $64M in FY2025.
Based on SEC 10-K filings.
$64M in FY2025 with a 5-year CAGR of +16.5%.
Increased from $53M to $64M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +10.3%
- 5-Year CAGR
- +16.5%
- 10-Year CAGR
- -
Sector benchmark
#74 of 213 in Health CareTop 34% of 213This company $63.6M Sector average $722.3M
▼
-91.2% below sector average
Key checks
Key Insights
- Xencor Inc's sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +16.5%, indicating consistent growth.
- In FY2025, sg&a expense increased 4.0% year-over-year.
- Ranks #140 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.27 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.6M | +4.0% |
| FY2024 | $61.2M | +14.7% |
| FY2023 | $53.4M | +12.4% |
| FY2022 | $47.5M | +95.5% |
| FY2021 | $24.3M | -18.2% |
| FY2020 | $29.7M | +69.6% |
| FY2019 | $17.5M | +33.5% |
| FY2018 | $13.1M | -25.1% |
| FY2017 | $17.5M | +33.5% |
| FY2016 | $13.1M | +9.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026